SAN FRANCISCO, April 26, 2021 -- Quit Genius, the world's first digital clinic for treating multiple addictions, announced today that its digital alcohol addiction treatment program is now live in the U.S. Large employers and health plans who have long offered the Quit Genius tobacco solution to their populations have already opted to add its new alcohol program as well, effective immediately.
Alcohol and drug use are at crisis levels in the U.S. A survey conducted in March 2021, by Quit Genius of 1,075 full- and part-time workers, found increasing use of alcohol and drugs during the pandemic, especially among those working remotely.
Highlights of the Quit Genius survey include:
People working remotely during the pandemic were more likely to report increased alcohol and drug use:
Access to treatment has also been impacted by the pandemic, which caused delays and reduced access to programs people use to maintain sobriety. There has also been a disruption in routines and increased social isolation, both of which can cause addictions to spiral.
"Quit Genius has reinvented alcohol addiction treatment for the 21st century, with an effective and easily accessible digital option," said Dr. Yusuf Sherwani, M.D., co-founder and CEO of Quit Genius. "We've taken all the lessons learned from our tobacco and vaping programs and applied them, through a creative approach, to alcohol addiction, which is the third leading cause of death in the U.S."
The Quit Genius program combines virtual behavioral therapy with approved medication and a connected breathalyzer to help people overcome alcohol addiction from the comfort and privacy of their own home. There is no other program like it in the U.S. It's modeled after the Quit Genius digital tobacco and vaping solution, already in wide use in the U.S. and Europe, and responsible for helping more than 60,000 people quit smoking since its launch in 2020. The average quit rate for people in the Quit Genius tobacco program is 52 percent. The Quit Genius approach has been validated in a randomized-controlled trial and six peer-reviewed studies.
Employees gain access to Quit Genius at no cost through their employer or health plan. At any time, they can confidentially register for a Quit Genius account and begin working with a licensed drug and alcohol counselor who will determine the level of help the employee needs. Through the Quit Genius Addiction Care Navigator, employees and members are guided to the most appropriate treatment.
Program participants have access to a dedicated care management team through telemedicine appointments, unlimited psychological therapy, medication to curb cravings, if needed, and a connected breathalyzer device. The solution also delivers Cognitive Behavioral Therapy modules delivered through the Quit Genius mobile app. Where traditional providers focus on a fixed 30-90 day program, Quit Genius tailors the length of the treatment to the member's needs with a focus on long-term sustained success.
"In these times, digital clinics for addiction can be a lifeline," said Dr. Sherwani, who founded Quit Genius with two other physicians after witnessing firsthand the ravages of addiction while working in hospitals. "We're really excited to have made this new approach to alcohol addiction a reality."
Quit Genius is the world's first digital clinic for treating nicotine, alcohol and opioid addictions. Built on the evidence-based practice of Medication-Assisted Treatment (MAT), Quit Genius combines virtual behavioral therapy with approved medication and connected devices to help employers tackle the high cost of addiction in the workplace while improving the lives of their employees. To-date, Quit Genius has helped more than 750,000 people improve their lives and quit their addictions. The company integrates with health plans, pharmacy benefit managers and wellness platforms to deliver a turnkey implementation experience. Visit quitgenius.com for more information.